{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T07:42:45Z","timestamp":1779090165076,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.ejmech.2019.06.094","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T19:40:32Z","timestamp":1562182832000},"page":"805-827","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Synthesis and biological evaluation of novel benzylidene-succinimide derivatives as noncytotoxic antiangiogenic inhibitors with anticolorectal cancer activity in\u00a0vivo"],"prefix":"10.1016","volume":"179","author":[{"given":"Kaixiu","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yafeng","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feifei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanfan","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conghai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2087-6013","authenticated-orcid":false,"given":"Jun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0149-2150","authenticated-orcid":false,"given":"Yi","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.06.094_bib1","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1039\/C8FO00850G","article-title":"Chemopreventive effects of some popular phytochemicals on human colon cancer: a review","volume":"9","author":"Zhao","year":"2018","journal-title":"Food Funct."},{"key":"10.1016\/j.ejmech.2019.06.094_bib2","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ypmed.2018.12.004","article-title":"Progress of colorectal cancer screening in United States: past achievements and future challenges","volume":"120","author":"Montminy","year":"2019","journal-title":"Prev. Med."},{"key":"10.1016\/j.ejmech.2019.06.094_bib3","doi-asserted-by":"crossref","first-page":"8533","DOI":"10.1002\/jcp.27806","article-title":"MicroRNA: a new player in response to therapy for colorectal cancer","volume":"234","author":"Sarvizadeh","year":"2019","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.ejmech.2019.06.094_bib4","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ejca.2018.12.019","article-title":"Treatment sequencing in metastatic colorectal cancer","volume":"109","author":"Modest","year":"2019","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.ejmech.2019.06.094_bib5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/1878-0261.12461","article-title":"Therapeutic cancer prevention: achievements and ongoing challenges - a focus on breast and colorectal cancer","volume":"13","author":"Serrano","year":"2019","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.ejmech.2019.06.094_bib6","article-title":"Deciphering biological characteristics of tumorigenic subpopulations in human colorectal cancer reveals cellular plasticity","volume":"21","author":"Mirzaei","year":"2016","journal-title":"J.\u00a0Res. Med. Sci."},{"key":"10.1016\/j.ejmech.2019.06.094_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.dld.2013.07.002","article-title":"Options for metastatic colorectal cancer beyond the second line of treatment","volume":"46","author":"Foubert","year":"2014","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.ejmech.2019.06.094_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.biocel.2019.02.010","article-title":"Targeting cancer stem cells as therapeutic approach in the treatment of colorectal cancer","volume":"110","author":"Parizadeh","year":"2019","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ejmech.2019.06.094_bib9","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/jcp.25801","article-title":"MicroRNAs: potential candidates for diagnosis and treatment of colorectal cancer","volume":"233","author":"Moridikia","year":"2018","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.ejmech.2019.06.094_bib10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jep.2018.05.039","article-title":"Jianpi Jiedu decoction, a traditional Chinese medicine formula, inhibits tumorigenesis, metastasis, and angiogenesis through the mTOR\/HIF-1 alpha\/VEGF pathway","volume":"224","author":"Peng","year":"2018","journal-title":"J.\u00a0Ethnopharmacol."},{"key":"10.1016\/j.ejmech.2019.06.094_bib11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s40265-018-1037-9","article-title":"Targeting angiogenesis in colorectal carcinoma","volume":"79","author":"Lopez","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.ejmech.2019.06.094_bib12","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1056\/NEJM197111182852108","article-title":"Tumor angiogenesis: therapeutic implications","volume":"285","author":"Folkman","year":"1971","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2019.06.094_bib13","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2019.06.094_bib14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1210\/edrv.18.1.0287","article-title":"The biology of vascular endothelial growth factor","volume":"18","author":"Ferrara","year":"1997","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ejmech.2019.06.094_bib15","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3892\/ol.2017.6142","article-title":"Regorafenib diminishes the expression and secretion of angiogenesis and metastasis associated proteins and inhibits cell invasion via NF-kappa B inactivation in SK-Hep1 cells","volume":"14","author":"Liu","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ejmech.2019.06.094_bib16","article-title":"Anti-angiogenesis therapy and gap junction inhibition reduce MDA-MB-231 breast cancer cell invasion and metastasis in\u00a0vitro and in\u00a0vivo","volume":"5","author":"Zibara","year":"2015","journal-title":"Sci. Rep. UK"},{"key":"10.1016\/j.ejmech.2019.06.094_bib17","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.2147\/OTT.S132558","article-title":"The influence of vascular endothelial growth factor-A and matrix metalloproteinase-2 and-9 in angiogenesis, metastasis, and prognosis of endometrial cancer","volume":"10","author":"Mahecha","year":"2017","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ejmech.2019.06.094_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.pharmthera.2017.02.037","article-title":"PI3K-AKT-mTOR inhibitors in breast cancers: from tumor cell signaling to clinical trials","volume":"175","author":"Dey","year":"2017","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.ejmech.2019.06.094_bib19","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cbi.2017.07.017","article-title":"A\u00a0marine sponge alkaloid derivative 4-chloro fascaplysin inhibits tumor growth and VEGF mediated angiogenesis by disrupting PI3K\/Akt\/mTOR signaling cascade","volume":"275","author":"Sharma","year":"2017","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2019.06.094_bib20","doi-asserted-by":"crossref","first-page":"5167","DOI":"10.3748\/wjg.v23.i28.5167","article-title":"Fibroblast-derived CXCL12\/SDF-1 alpha promotes CXCL6 secretion and co-operatively enhances metastatic potential through the PI3K\/Akt\/mTOR pathway in colon cancer","volume":"23","author":"Ma","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejmech.2019.06.094_bib21","first-page":"4463","article-title":"Wogonoside inhibits cell growth and induces mitochondrial-mediated autophagy-related apoptosis in human colon cancer cells through the PI3K\/AKT\/mTOR\/p70S6K signaling pathway","volume":"15","author":"Han","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.ejmech.2019.06.094_bib22","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejphar.2016.02.044","article-title":"Ghrelin induces colon cancer cell proliferation through the GHS-R, Ras, PI3K, Akt, and mTOR signaling pathways","volume":"776","author":"Lien","year":"2016","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.06.094_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.bcp.2016.11.009","article-title":"A\u00a0tumoural angiogenic gateway blocker, Benzophenone-1B represses the HIF-1 alpha nuclear translocation and its target gene activation against neoplastic progression","volume":"125","author":"Thirusangu","year":"2017","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.06.094_bib24","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/onc.2009.441","article-title":"Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics","volume":"29","author":"Semenza","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2019.06.094_bib25","article-title":"Combination of non-cytotoxic agents with anti-angiogenic activity for metronomic therapy of solid tumors: antitumor activity and biological effects","volume":"18","author":"Noberasco","year":"2007","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ejmech.2019.06.094_bib26","article-title":"A\u00a0non-cytotoxic compound blocks angiogenesis and decreases tumor burden in the TAg-RB retinoblastoma mouse","volume":"58","author":"Corson","year":"2017","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejmech.2019.06.094_bib27","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ejmech.2018.07.032","article-title":"Synthesis and cytotoxic studies of novel 5-phenylisatin derivatives and their anti-migration and anti-angiogenic evaluation","volume":"156","author":"Zhang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.094_bib28","article-title":"Fe-MIL-101 exhibits selective cytotoxicity and inhibition of angiogenesis in ovarian cancer cells via downregulation of MMP","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep. UK"},{"key":"10.1016\/j.ejmech.2019.06.094_bib29","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1021\/bc200629f","article-title":"Dual peptide nucleic acid- and peptide-functionalized shell cross-linked nanoparticles designed to target mRNA toward the diagnosis and treatment of acute lung injury","volume":"23","author":"Shrestha","year":"2012","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejmech.2019.06.094_bib30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bios.2018.08.044","article-title":"Electrically controlled Michael addition: addressing of covalent immobilization of biological receptors","volume":"121","author":"Hammami","year":"2018","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.ejmech.2019.06.094_bib31","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ejmech.2014.07.077","article-title":"Michael acceptor approach to the design of new salvinorin A-based high affinity ligands for the kappa-opioid receptor","volume":"85","author":"Polepally","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.094_bib32","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1128\/AAC.49.2.749-759.2005","article-title":"Discovering the mechanism of action of novel antibacterial agents through transcriptional profiling of conditional mutants","volume":"49","author":"Freiberg","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2019.06.094_bib33","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1016\/j.bmcl.2010.07.141","article-title":"Cytotoxic cycloartane triterpene and rare isomeric bisclerodane diterpenes from the leaves of Polyalthia longifolia var. pendula","volume":"20","author":"Sashidhara","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.06.094_bib34","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.mvr.2011.10.004","article-title":"Angiogenesis inhibition by the maleimide-based small molecule GNX-686","volume":"83","author":"Nowak-Sliwinska","year":"2012","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.ejmech.2019.06.094_bib35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nbt.2520","article-title":"Back on target","volume":"31","author":"Webb","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2019.06.094_bib36","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1021\/bc5005262","article-title":"Long-term stabilization of maleimide-thiol conjugates","volume":"26","author":"Fontaine","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejmech.2019.06.094_bib37","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/nbt.2968","article-title":"Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates","volume":"32","author":"Lyon","year":"2014","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2019.06.094_bib38","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.2108","article-title":"Conjugation site modulates the in\u00a0vivo stability and therapeutic activity of antibody-drug conjugates","volume":"30","author":"Shen","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejmech.2019.06.094_bib39","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1021\/bc200148v","article-title":"Tunable degradation of maleimide-thiol adducts in reducing environments","volume":"22","author":"Baldwin","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.ejmech.2019.06.094_bib40","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1002\/anie.201508118","article-title":"Exocyclic olefinic maleimides: synthesis and application for stable and thiol-selective bioconjugation","volume":"55","author":"Kalia","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2019.06.094_bib41","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1016\/j.bmcl.2017.10.046","article-title":"Synthesis and biological evaluation of thiazole derivatives as GPR119 agonists","volume":"27","author":"Kim","year":"2017","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.06.094_bib42","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/cmdc.201100166","article-title":"Toward the Discovery of novel anti-HIV drugs. Second-generation inhibitors of the cellular ATPase DDX3 with improved anti-HIV activity: synthesis, structure-activity relationship analysis, cytotoxicity studies, and target validation","volume":"6","author":"Maga","year":"2011","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2019.06.094_bib43","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1021\/jm901183d","article-title":"Discovery of (Z)-5-(4-Methoxybenzylidene)thiazolidine-2,4-dione, a readily available and orally active glitazone for the treatment of concanavalin A-induced acute liver injury of BALB\/c mice","volume":"53","author":"Luo","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.094_bib44","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/cmdc.201800033","article-title":"Synthesis and biological evaluation of indole-2-carbohydrazide derivatives as anticancer agents with anti-angiogenic and antiproliferative activities","volume":"13","author":"Zhang","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2019.06.094_bib45","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1039\/c3ob40368h","article-title":"Novel 5-anilinoquinazoline-8-nitro derivatives as inhibitors of VEGFR-2 tyrosine kinase: synthesis, biological evaluation and molecular docking","volume":"11","author":"Xi","year":"2013","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.ejmech.2019.06.094_bib46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ejmech.2017.12.016","article-title":"Synthesis and biological evaluation of novel 1-(aryl-aldehyde-oxime) uracil derivatives as a new class of thymidine phosphorylase inhibitors","volume":"144","author":"Zhao","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.06.094_bib47","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nrd2130","article-title":"Discovery and development of sorafenib: a multikinase inhibitor for treating cancer","volume":"5","author":"Wilhelm","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2019.06.094_bib48","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/bjc.2012.153","article-title":"Regorafenib (BAY 73-4506) in advanced colorectal cancer: a phase I study","volume":"106","author":"Strumberg","year":"2012","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.ejmech.2019.06.094_bib49","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1200\/JCO.2005.03.6723","article-title":"Phase II placebo-controlled randomized discontinuation trial of sorafnib in patients with metastatic renal cell carcinoma","volume":"24","author":"Ratain","year":"2006","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ejmech.2019.06.094_bib50","doi-asserted-by":"crossref","first-page":"12534","DOI":"10.1002\/chem.201002183","article-title":"Bicyclic guanidine-catalyzed direct asymmetric allylic addition of N-aryl alkylidene-succinimides","volume":"16","author":"Wang","year":"2010","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2019.06.094_bib51","article-title":"Effects of polynitrogen compounds on the activity of recombinant human Hypoxia inducible factor-1 alpha prolyl hydroxylase 3 in Escherichia coli","volume":"25","author":"Geng","year":"2011","journal-title":"FASEB J."},{"issue":"59","key":"10.1016\/j.ejmech.2019.06.094_bib52","doi-asserted-by":"crossref","first-page":"ref1","DOI":"10.1126\/scisignal.259re1","article-title":"Positive and negative modulation of angiogenesis by VEGFR1 ligands","volume":"2","author":"Cao","year":"2009","journal-title":"Sci. Signal."},{"key":"10.1016\/j.ejmech.2019.06.094_bib53","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.1016\/S1471-4914(02)02317-1","article-title":"HIF-1 and tumor progression: pathophysiology and therapeutics","volume":"8","author":"Semenza","year":"2002","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ejmech.2019.06.094_bib54","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1200\/JCO.2013.48.9229","article-title":"Identification of somatic genomic alterations in circulating tumors cells: another step forward in non-small-cell lung cancer?","volume":"31","author":"Costa","year":"2013","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.ejmech.2019.06.094_bib55","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nrc3627","article-title":"VEGF targets the tumour cell","volume":"13","author":"Goel","year":"2013","journal-title":"Nat. Rev. Canc."},{"key":"10.1016\/j.ejmech.2019.06.094_bib56","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","article-title":"Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis","volume":"86","author":"Hanahan","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2019.06.094_bib57","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1053\/sonc.2002.37263","article-title":"Role of angiogenesis in tumor growth and metastasis","volume":"29","author":"Folkman","year":"2002","journal-title":"Semin. Oncol."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341930621X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352341930621X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:04:39Z","timestamp":1759327479000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352341930621X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":57,"alternative-id":["S022352341930621X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.06.094","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and biological evaluation of novel benzylidene-succinimide derivatives as noncytotoxic antiangiogenic inhibitors with anticolorectal cancer activity in\u00a0vivo","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.06.094","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}